SpyGlass Pharma, Inc. Research and Development Expense
SpyGlass Pharma, Inc. (SGP) reported Research and Development Expense of $10.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- SpyGlass Pharma, Inc. research and development expense for the quarter ending 2026-06-30 was $10.94M, a 49.22% increase year-over-year.
- SpyGlass Pharma, Inc. research and development expense for the quarter ending 2026-03-31 was $8.54M, a 41.14% increase year-over-year.
- SpyGlass Pharma, Inc. research and development expense for the quarter ending 2025-06-30 was $7.33M.
- SpyGlass Pharma, Inc. research and development expense for the quarter ending 2025-03-31 was $6.05M.
- SpyGlass Pharma, Inc. research and development expense for fiscal 2025 was $29.18M, a 46.03% increase from fiscal 2024.
- SpyGlass Pharma, Inc. research and development expense for fiscal 2024 was $19.98M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $10.94M 10-Q · filed 2026-08-06 | $19.48M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.54M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $29.18M 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $7.33M 10-Q · filed 2026-08-06 | $13.38M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $6.05M 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $19.98M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |